Adding irradiation before transplant improves long-term results and should change practice
Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an aggressive stem cell transplant regimen.
The researchers, publishing in the Jan. 4 issue of the New England Journal of Medicine, found significantly improved survival among patients with a severe form of scleroderma who underwent chemotherapy, whole body radiation and a stem cell transplant. Patients also had less need for immune suppressant drugs after transplant.
“Scleroderma hardens the skin and connective tissues and in its severe form leads to fatal organ failure, most often the lungs” said lead author Keith Sullivan, M.D., James B. Wyngaarden Professor of Medicine and Cellular Therapy at Duke. “In these severe cases, conventional drug therapies are not very effective long-term, so new approaches are a priority.”
Earlier publications suggested that stem cell transplant might be a viable treatment, using less intensive treatment without irradiation. These studies showed that reduced-intensity stem cell transplant improved survival, but the disease often returned and patient safety remained a concern. As a result, conventional immunosuppressive drug treatment remained the standard of care in the U.S.
In the current study, Sullivan and colleagues developed a transplant conditioning regimen that included high-dose chemotherapy plus whole-body radiation to fully wipe out the patient’s defective immune-forming system, with the aim of improving survival and diminishing the effects of the disease. They limited radiation by shielding patients’ kidneys and lungs while repopulating the blood and immune system.
Thirty-six scleroderma patients were randomly assigned to receive transplant. The regimen was designed to destroy the patients’ defective autoreactive immune system and replace it with their own blood stem cells that had been removed and treated to eliminate self-reacting lymphocytes.
For comparison, 39 additional patients were randomized to receive 12 monthly intravenous injections of cyclophosphamide, a conventional immune suppressing treatment for severe scleroderma.
“These results show that individuals with poor-prognosis scleroderma can improve and live longer and that these advances appear durable.”
The study was conducted over a 10-year period at 26 universities in the United States and Canada. The primary study endpoint at 54 months was a global rank composite score based on a hierarchy of scleroderma features including survival, organ function, quality of life and skin hardening. Results showed significant benefit with transplant: 67 percent of 1,404 pairwise comparisons favored transplant vs. 33 percent favoring cyclophosphamide.
By study endpoint, fewer transplant recipients resumed use of anti-scleroderma drugs (9 percent vs. 44 percent of controls). Overall survival at 72 months was 86 percent after transplant vs. 51 percent after cyclophosphamide — a highly significant benefit.
“These results show that individuals with poor-prognosis scleroderma can improve and live longer and that these advances appear durable,” Sullivan said.
Treatment-related mortality at the study endpoint of 54 months was 3 percent among transplant recipients while cyclophosphamide recipients had no treatment-related deaths. In the short term, transplant recipients also had more serious side effects, such as low blood counts and infections.
“Patients and their doctors should carefully weigh the pros and cons of intensive treatment with stem cell transplant, but this may hopefully set a new standard in this otherwise devastating autoimmune disease,” Sullivan said. “These advances show the value of medical research and clinical trials in finding better therapies to advance health.”
The Latest on: Stem cell transplant
- An Autologous Stem Cell-Based Therapy for Parkinson’s Diseaseon November 25, 2020 at 9:49 am
While cell therapies show promise in Parkinson's diseas, there's an ongoing debate about which therapy is best.
- Mapping out the mystery of blood stem cellson November 25, 2020 at 9:45 am
Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughout our life by looking at vast, uncharted regions of our genetic material that hold important ...
- Canadian Blood Services: Only half of donors follow through with stem cell transplantson November 24, 2020 at 5:18 pm
Canadian Blood Services is pleading to registered stem-cells donors to follow through with their commitments. The organization says that only 50 per cent of those potential donors who are registered ...
- Woman Meets Life-Saving Stem Cell Donor: A Story Of Thanksgivingon November 24, 2020 at 6:44 am
For the next few months, Goerler's platelets kept dropping, so she began chemotherapy for seven days straight every month to prepare for a stem cell transplant. She was told there is usually a ...
- New stem cell transplant unit came too late for Laura Hillieron November 23, 2020 at 6:17 am
Patients with rare blood disorders will now have better access to treatment, thanks to a new Stem Cell Transplant wing at the’ Juravins ...
- Global Stem Cell Therapy Market 2020: Market Growth, Trends, Revenue, Share and Demands Research Reporton November 22, 2020 at 7:53 pm
Global “ Stem Cell Therapy " Market 2024 Research Report provide in-depth study of the present state of the Industry. Initially, the report shows a basic overview of the industry including definitions ...
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis, Innovation Trends and Current Business Trends by 2025on November 20, 2020 at 11:25 pm
The Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is expected to exceed more than US$ 4.5 Billion ...
- This TikToker is dancing to raise money for her boyfriend’s stem cell transplanton November 19, 2020 at 7:27 pm
TikToker and musical artist Madison Olds is creating a series of dance videos to raise money for her boyfriend's stem cell treatment.
- Undesirable rejection mechanism identified in stem cell transplantationon November 19, 2020 at 4:09 am
In the treatment of leukemia, stem cell transplantation subsequent to chemotherapy and radiation can often engender severe adverse inflammatory reactions—especially in the skin or in the gut, since ...
- Immune mechanism responsible for adverse inflammatory reactions after stem cell transplant identifiedon November 19, 2020 at 3:42 am
In the treatment of leukemia, stem cell transplantation subsequent to chemotherapy and radiation can often engender severe adverse inflammatory reactions - especially in the skin or in the gut, since ...
via Google News and Bing News